+ 0.60
+ 0.4%

AXIM Biotechnologies Receives Patent For CBD Cream For Eczema

March 27, 2019 3:16 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
AXIM Biotechnologies Receives Patent For CBD Cream For Eczema

AXIM Biotechnologies Inc. (OTC:AXIM), a cannabinoid research and development company, has been issued a Notice of Allowance for a patent from the U.S. Patent and Trademark Office for a topical cream containing cannabinoids for the treatment of atopic dermatitis (eczema).

The Cannabis Capital Conference returns to Toronto April 17-18!

What Happened

The Notice of Allowance was granted for a patent application Axim filed Aug. 21, 2018. The cream includes two cannabinoids: cannabidiol (CBD) and cannabigerol (CBG), which were proven to provide anti-inflammatory and pain relief benefits.

It uses the company's proprietary formulation for relief of the itching, pain and inflammation that often accompany atopic dermatitis. 

Why It's Important

Axim said it expects that its topical cream will be one of the first CBG products available on the market — and it won't require a prescription. With this product, AXIM expects to enter an atopic dermatitis market that is valued at $5 billion.

What's Next

Axim, which counts Medical Marijuana Inc (OTC:MJNA) among its largest investors, said it expects to introduce the topical cream products to the market sometime in the third quarter of 2019, "likely delivered direct-to-consumer," CEO John Huemoeller told Benzinga. 

The company has a number of other products in its pipeline, including a toothpaste containing CBD and CBG that is ikely to be available in the third quarter as well, Huemoeller he said. 

Related Links:

This Research Firm Sees A Huge Opportunity In The European CBD Market

Resolve Digital Health's Medical Cannabis Vaporizer Approved By Health Canada


Cannabis News Markets

Related Articles

The Week In Cannabis: Stocks Spike By Double Digits On Earnings, Strong Sales, Financings

Cannabis stocks widely outperformed the markets after a slew of financing deals and strong earnings reports. read more

Cannabis Movers & Shakers: Next Green, Cannabis Control Commission, Willow, TruTrace, HEXO, Bengal Capital, MediPharm Labs, NIHC

Here is a summary of the latest leadership changes within the cannabis industry. read more

HempFusion Wellness Debuts In Europe Via Deal With Ireland CPG Distributor

Health and wellness CBD company HempFusion Wellness Inc. (TSX: CBD.U) is expanding to Europe through a deal with an undisclosed consumer goods distributor in Ireland. read more

Vext Science Upsizes Bought Deal Public Offering To Raise $18M

Vertically integrated CBD company Vext Science Inc. (CSE: VEXT) (OTCQX: VEXTF) is poised to raise $18 million through a bought deal offering of its units. read more

From Peace Corps To Peace Pipes: Steve Sakala Shows CBD Companies How To Be Eco-Friendly

There's zero excuse for consumer packaged goods companies to not be plastic negative, says Steve Sakala. Take his work in the cannabis industry. Like most industries, the world of weed has a major sustainability problem. It creates at least 150 million tons of waste annually, mainly due to single-use plastic packaging. read more